In vitro characterization of human peptide transporter hPEPT1 interactions and passive permeation studies of short cationic antimicrobial peptides

Journal of Medicinal Chemistry

Volumn 54, Issue 7, 2011, Pages 2422-2432

  Flaten, Gril Eide ^a   Kottra, Gabor ^b   Stensen, Wenche ^c   Isaksen, Geir ^a   Karstad, Rasmus ^a   Svendsen, John S ^a,c   Daniel, Hannelore ^b   Svenson, Johan ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c LYTIX BIOPHARMA AS   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDE DERIVATIVE; LACTOFERRICIN; PEPTIDE TRANSPORTER 1; TRIPEPTIDE DERIVATIVE;

ANIMAL CELL; ARTICLE; HUMAN; HYDROPHOBICITY; NONHUMAN; PHOSPHOLIPID VESICLE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TRANSPORT; XENOPUS LAEVIS;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIA; HUMANS; MICROBIAL SENSITIVITY TESTS; PERMEABILITY; PHOSPHOLIPIDS; PROTEIN BINDING; SYMPORTERS;

EID: 79953793971     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm1015704     Document Type: Article

References (51)

1. Dobson, P. D.; Kell, D. B. Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule Nat. Rev. Drug Discovery 2008, 7, 205-220 (Pubitemid 351321232)
2. Dobson, P. D.; Lanthaler, K.; Oliver, S. G.; Kell, D. B. Implications of the dominant role of transporters in drug uptake by cells Curr. Top. Med. Chem. 2009, 9, 163-181
3. Sugano, K.; Kansy, M.; Artursson, P.; Avdeef, A.; Bendels, S.; Di, L.; Ecker, G. F.; Faller, B.; Fischer, H.; Gerebtzoff, G.; Lennernaes, H.; Senner, F. Coexistence of passive and carrier-mediated processes in drug transport Nat. Rev. Drug Discovery 2010, 9, 597-614
4. Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv. Drug Delivery Rev. 1997, 23, 3-25 (Pubitemid 27046991)
5. Payne, D. J.; Gwynn, M. N.; Holmes, D. J.; Pompliano, D. L. Drugs for bad bugs: confronting the challenges of antibacterial discovery Nat. Rev. Drug Discovery 2007, 6, 29-40 (Pubitemid 46020284)
6. +/peptide symporter (PEPT1), the uptake into Caco-2 cell monolayers and the transepithelial flux Pharm. Res. 1999, 16, 55-61 (Pubitemid 29047457)
7. Temple, C. S.; Stewart, A. K.; Meredith, D.; Lister, N. A.; Morgan, K. M.; Collier, I. D.; Vaughan-Jones, R. D.; Boyd, C. A. R.; Bailey, P. D.; Bronk, J. R. Peptide mimics as substrates for the intestinal peptide transporter J. Biol. Chem. 1998, 273, 20-22 (Pubitemid 28042169)
8. Brodin, B.; Nielsen, C. U.; Steffansen, B.; Frokjaer, S. Transport of peptidomimetic drugs by the intestinal di/tri-peptide transporter, PepT1 Pharmacol. Toxicol. 2002, 90, 285-296 (Pubitemid 34713193)
9. Andersen, R.; Jorgensen, F. S.; Olsen, L.; Vabeno, J.; Thorn, K.; Nielsen, C. U.; Steffansen, B. Development of a QSAR model for binding of tripeptides and tripeptidomimetics to the human intestinal di-/tripeptide transporter hPEPT1 Pharm. Res. 2006, 23, 483-492
10. Vabeno, J.; Nielsen, C. U.; Ingebrigtsen, T.; Lejon, T.; Steffansen, B.; Luthman, K. Dipeptidomimetic ketomethylene isosteres as pro-moieties for drug transport via the human intestinal di-/tripeptide transporter hPEPT1: design, synthesis, stability, and biological investigations J. Med. Chem. 2004, 47, 4755-4765 (Pubitemid 39195565)
11. Bailey, P. D.; Boyd, C. A. R.; Bronk, J. R.; Collier, I. D.; Meredith, D.; Morgan, K. M.; Temple, C. S. How to make drugs orally active: a substrate template for peptide transporter PepT1 Angew. Chem. 2000, 39, 506-508 (Pubitemid 30101723)
12. Fei, Y. J.; Kanai, Y.; Nussberger, S.; Ganapathy, V.; Leibach, F. H.; Romero, M. F.; Singh, S. K.; Boron, W. F.; Hediger, M. A. Expression cloning of a mammalian proton-coupled oligopeptide transporter Nature 1994, 368, 563-566 (Pubitemid 24118776)
13. + symporter in the renal brush-border membrane J. Biol. Chem. 1992, 267, 9565-9573
14. Haug, B. E.; Stensen, W.; Kalaaji, M.; Rekdal, O.; Svendsen, J. S. Synthetic antimicrobial peptidomimetics with therapeutic potential J. Med. Chem. 2008, 51, 4306-4314 (Pubitemid 352032455)
15. Haug, B. E.; Stensen, W.; Stiberg, T.; Svendsen, J. S. Bulky nonproteinogenic amino acids permit the design of very small and effective cationic antibacterial peptides J. Med. Chem. 2004, 47, 4159-4162 (Pubitemid 39045422)
16. Svenson, J.; Karstad, R.; Flaten, G. E.; Brandsdal, B. O.; Brandl, M.; Svendsen, J. S. Altered activity and physicochemical properties of short cationic antimicrobial peptides by incorporation of arginine analogues Mol. Pharmaceutics 2009, 6, 996-1005
17. Svenson, J.; Stensen, W.; Brandsdal, B. O.; Haug, B. E.; Monrad, J.; Svendsen, J. S. Antimicrobial peptides with stability toward tryptic degradation Biochemistry 2008, 47, 3777-3788 (Pubitemid 351431368)
18. Svenson, J.; Vergote, V.; Karstad, R.; Burvenich, C.; Svendsen, J. S.; De Spiegeleer, B. Metabolic fate of lactoferricin-based antimicrobial peptides: effect of truncation and incorporation of amino acid analogs on the in vitro metabolic stability J. Pharm. Exp. Ther. 2010, 332, 1032-1039
19. Karstad, R.; Isaksen, G.; Brandsdal, B. O.; Svendsen, J. S.; Svenson, J. Unnatural amino acid side chains as S1, S1′, and S2′ probes yield cationic antimicrobial peptides with stability toward chymotryptic degradation J. Med. Chem. 2010, 53, 5558-5566
20. Hamman, J. H.; Enslin, G. M.; Kotze, A. F. Oral delivery of peptide drugs: barriers and developments BioDrugs 2005, 19, 165-177 (Pubitemid 40994232)
21. Giannis, A. Peptidomimetics for receptor ligands discovery, development, and medical perspectives Angew. Chem. 1993, 32, 1244-1267
22. Flaten, G. E.; Dhanikula, A. B.; Luthman, K.; Brandl, M. Drug permeability across a phospholipid vesicle based barrier: a novel approach for studying passive diffusion Eur. J. Pharm. Sci. 2006, 27, 80-90 (Pubitemid 41728258)
23. Zasloff, M. Antimicrobial peptides of multicellular organisms Nature 2002, 415, 389-395 (Pubitemid 34100944)
24. Melo, M. N.; Ferre, R.; Castanho, M. OPINION antimicrobial peptides: linking partition, activity and high membrane-bound concentrations Nat. Rev. Microbiol. 2009, 7, 245-250
25. Yeaman, M. R.; Yount, N. Y. Mechanisms of antimicrobial peptide action and resistance Pharmacol. Rev. 2003, 55, 27-55 (Pubitemid 36268398)
26. Bremner, J. B.; Keller, P. A.; Pyne, S. G.; Boyle, T. P.; Brkic, Z.; David, D. M.; Garas, A.; Morgan, J.; Robertson, M.; Somphol, K.; Miller, M. H.; Howe, A. S.; Ambrose, P.; Bhavnani, S.; Fritsche, T. R.; Biedenbach, D. J.; Jones, R. N.; Buckheit, R. W.; Watson, K. M.; Baylis, D.; Coates, J. A.; Deadman, J.; Jeevarajah, D.; McCracken, A.; Rhodes, D. I. Binaphthyl-based dicationic peptoids with therapeutic potential Angew. Chem. 2010, 49, 537-540
27. Hansen, T.; Alst, T.; Havelkova, M.; Strom, M. B. Antimicrobial activity of small beta-peptidomimeties based on the pharmacophore model of short cationic antimicrobial peptides J. Med. Chem. 2010, 53, 595-606
28. Strom, M. B.; Haug, B. E.; Skar, M. L.; Stensen, W.; Stiberg, T.; Svendsen, J. S. The pharmacophore of short cationic antibacterial peptides J. Med. Chem. 2003, 46, 1567-1570 (Pubitemid 36444211)
29. Haug, B. E.; Stensen, W.; Svendsen, J. S. Application of the Suzuki-Miyaura cross-coupling to increase antimicrobial potency generates promising novel antibacterials Bioorg. Med. Chem. Lett. 2007, 17, 2361-2364 (Pubitemid 46484291)
30. Brandsch, M. Transport of drugs by proton-coupled peptide transporters: pearls and pitfalls Expert Opin. Drug Metab. Toxicol. 2009, 5, 887-905
31. +/peptide cotransporter PEPT1 J. Med. Chem. 2005, 48, 4410-4419 (Pubitemid 40884943)
32. Larsen, S. B.; Omkvist, D. H.; Brodin, B.; Nielsen, C. U.; Steffansen, B.; Olsen, L.; Jorgensen, F. S. Discovery of ligands for the human intestinal di-/tripeptide transporter (hPEPT1) using a QSAR-assisted virtual screening strategy ChemMedChem 2009, 4, 1439-1445
33. Wagner, C. A.; Friedrich, B.; Setiawan, I.; Lang, F.; Broer, S. The use of Xenopus laevis oocytes for the functional characterization of heterologously expressed membrane proteins Cell. Physiol. Biochem. 2000, 10, 1-12
34. Vig, B. S.; Stouch, T. R.; Timoszyk, J. K.; Quan, Y.; Wall, D. A.; Smith, R. L.; Faria, T. N. Human PEPT1 pharmacophore distinguishes between dipeptide transport and binding J. Med. Chem. 2006, 49, 3636-3644 (Pubitemid 43902468)
35. +/peptide symporter PEPT1: structure-affinity relationships Eur. J. Pharm. Sci. 2004, 21, 53-60 (Pubitemid 38050203)
36. +/peptide cotransporters FEBS J. 2007, 274, 5905-5914 (Pubitemid 350045802)
37. Omkvist, D. H.; Larsen, S. B.; Nielsen, C. U.; Steffansen, B.; Olsen, L.; JArgensen, F. S.; Brodin, B. A quantitative structure-activity relationship for translocation of tripeptides via the human proton-coupled peptide transporter, hPEPT1 (SLC15A1) AAPS J. 2010, 385-396
38. Kanzer, J.; Tho, I.; Flaten, G. E.; Magerlein, M.; Holig, P.; Fricker, G.; Brandl, M. In-vitro permeability screening of melt extrudate formulations containing poorly water-soluble drug compounds using the phospholipid vesicle-based barrier J. Pharm. Pharmacol. 2010, 62, 1591-1598
39. Salamat-Miller, N.; Johnston, T. P. Current strategies used to enhance the paracellular transport of therapeutic polypeptides across the intestinal epithelium Int. J. Pharm. 2005, 294, 201-216 (Pubitemid 40462336)
40. Foger, F.; Kopf, A.; Loretz, B.; Albrecht, K.; Bernkop-Schnurch, A. Correlation of in vitro and in vivo models for the oral absorption of peptide drugs Amino Acids 2008, 35, 233-241 (Pubitemid 351799196)
41. QikProp, version 3.3; Schrödinger, LLC: New York, NY, 2010.
42. Duffy, E. M.; Jorgensen, W. L. Prediction of properties from simulations: free energies of solvation in hexadecane, octanol, and water J. Am. Chem. Soc. 2000, 122, 2878-2888 (Pubitemid 30191048)
43. Knipp, G. T.; Ho, N. F. H.; Barsuhn, C. L.; Borchardt, R. T. Paracellular diffusion in Caco-2 cell monolayers: effect of perturbation on the transport of hydrophilic compounds that vary in charge and size J. Pharm. Sci. 1997, 86, 1105-1110 (Pubitemid 27430913)
44. Knipp, G. T.; Velde, D. G. V.; Siahaan, T. J.; Borchardt, R. T. The effect of beta-turn structure on the passive diffusion of peptides across Caco-2 cell monolayers Pharm. Res. 1997, 14, 1332-1340 (Pubitemid 27481063)
45. Wright, L. R.; Rothbard, J. B.; Wender, P. A. Guanidinium rich peptide transporters and drug delivery Curr. Protein Pept. Sci. 2003, 4, 105-124 (Pubitemid 36834010)
46. Kirschberg, T. A.; VanDeusen, C. L.; Rothbard, J. B.; Yang, M.; Wender, P. A. Arginine-based molecular transporters: the synthesis and chemical evaluation of releasable Taxol-transporter conjugates Org. Lett. 2003, 5, 3459-3462 (Pubitemid 37487437)
47. Rothbard, J. B.; Garlington, S.; Lin, Q.; Kirschberg, T.; Kreider, E.; McGrane, P. L.; Wender, P. A.; Khavari, P. A. Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation Nat. Med. 2000, 6, 1253-1257
48. Futaki, S.; Suzuki, T.; Ohashi, W.; Yagami, T.; Tanaka, S.; Ueda, K.; Sugiura, Y. Arginine-rich peptides: an abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery J. Biol. Chem. 2001, 276, 5836-5840
49. Boll, M.; Markovich, D.; Weber, W. M.; Korte, H.; Daniel, H.; Murer, H. Expression cloning of a cDNA from rabbit small-intestine related to proton-coupled transport of peptides, beta-lactam antibiotics and ACE-inhibitors Pfluegers Arch. 1994, 429, 146-149 (Pubitemid 24353843)
50. Flaten, G. E.; Bunjes, H.; Luthman, K.; Brandl, M. Drug permeability across a phospholipid vesicle-based barrier-2. Characterization of barrier structure, storage stability and stability towards pH changes Eur. J. Pharm. Sci. 2006, 28, 336-343 (Pubitemid 44218739)
51. Flaten, G. E. The Phospholipid Vesicle-Based Barrier: A Novel Method for Passive Drug Permeability Screening. Ph.D. Thesis, University of Tromsø, Tromsø, Norway, 2007.